Overview Safety of Ramelteon in Subjects With Mild to Moderate Obstructive Sleep Apnea Status: Completed Trial end date: 2003-12-01 Target enrollment: Participant gender: Summary The purpose of this study is to assess the safety of ramelteon, once daily (QD), in individuals with obstructive sleep apnea. Phase: Phase 2 Details Lead Sponsor: Takeda